Trilogy Analytical

Pro-Pack Testing Laboratory, Inc. is a highly reputable, independent package testing laboratory located in Southern Illinois, just a short distance from downtown St. Louis. With over 30 years of experience, they are nationally recognized for their commitment to accuracy and high standards in package testing. Specializing in a wide range of package testing capabilities, Pro-Pack is dedicated to ensuring cost savings and safety in shipping through supply chains. Their expert team utilizes state-of-the-art equipment and testing methods to verify package design and provide pre-shipment inspections for all levels of packaging.Generated from the website

Founded in 1929, St. Louis Testing Laboratories, Inc. is a privately owned, independent commercial testing laboratory. The company performs a wide range of services, such as performing analyses, testing, inspection, in the specialized fields of nondestructive testing, metallurgical analysis, mechanical testing, organic, inorganic, environmental, and chemical analyses. It also offers services like chemical testing, environmental testing, metallurgic testing, nondestructive testing, mechanical testing, product testing, electronics testing, scope of accreditation and coating testing. St. Louis Testing Laboratories, Inc. is located in St Louis, Mo.

Cofactor Genomics is a leading biotech company based in Saint Louis, MO, specializing in predictive diagnostics for cancer patients. Their groundbreaking OncoPrism assay accurately predicts patient response to immunotherapy, revolutionizing the field of precision medicine. With partnerships with over 24 healthcare systems, Cofactor is at the forefront of the national PREDAPT trial, studying 11 solid tumor cancers and providing clinicians and patients with better tools for treatment decisions. Driven by a multidimensional approach, Cofactor Genomics is dedicated to advancing human health and precision medicine. Their diagnostic pipeline includes ongoing clinical studies and validation for various indications in immune-oncology, such as cervical cancer, colorectal cancer, and non-small-cell lung cancer. With a focus on predictive biomarkers and cutting-edge technology, Cofactor is shaping the future of cancer treatment and improving patient outcomes.Generated from the website